$8.65
1.14% yesterday
Nasdaq, Nov 25, 10:00 pm CET
ISIN
CA92663R1055
Symbol
VMD

Viemed Healthcare Inc Stock price

$8.65
-0.59 6.39% 1M
+1.59 22.52% 6M
+0.80 10.19% YTD
+0.63 7.86% 1Y
+3.25 60.19% 3Y
+2.45 39.52% 5Y
+6.86 382.27% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
-0.10 1.14%
ISIN
CA92663R1055
Symbol
VMD
Sector

Key metrics

Market capitalization $336.80m
Enterprise Value $334.55m
P/E (TTM) P/E ratio 33.67
EV/FCF (TTM) EV/FCF 95.31
EV/Sales (TTM) EV/Sales 1.56
P/S ratio (TTM) P/S ratio 1.57
P/B ratio (TTM) P/B ratio 2.70
Revenue growth (TTM) Revenue growth 26.22%
Revenue (TTM) Revenue $214.30m
EBIT (operating result TTM) EBIT $16.50m
Free Cash Flow (TTM) Free Cash Flow $3.51m
Cash position $11.35m
EPS (TTM) EPS $0.26
P/E forward 30.89
P/S forward 1.50
EV/Sales forward 1.49
Short interest 1.06%
Show more

Is Viemed Healthcare Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Viemed Healthcare Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

3 Analysts have issued a Viemed Healthcare Inc forecast:

3x Buy
100%

Analyst Opinions

3 Analysts have issued a Viemed Healthcare Inc forecast:

Buy
100%

Financial data from Viemed Healthcare Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
214 214
26% 26%
100%
- Direct Costs 87 87
29% 29%
40%
128 128
25% 25%
60%
- Selling and Administrative Expenses 83 83
27% 27%
39%
- Research and Development Expense 2.92 2.92
2% 2%
1%
41 41
23% 23%
19%
- Depreciation and Amortization 25 25
23% 23%
12%
EBIT (Operating Income) EBIT 17 17
23% 23%
8%
Net Profit 10 10
13% 13%
5%

In millions USD.

Don't miss a Thing! We will send you all news about Viemed Healthcare Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Viemed Healthcare Inc Stock News

Neutral
Seeking Alpha
17 days ago
Viemed Healthcare, Inc. (NASDAQ:VMD ) Q3 2024 Results Conference Call November 7, 2024 12:00 PM ET Company Participants Todd Zehnder - Chief Operating Officer Casey Hoyt - Chief Executive Officer Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Doug Cooper - Beacon Securities Ilya Zubkov - Freedom Broker Operator Greetings, and welcome to Viemed's Third Quarter 2024 Earn...
Neutral
GlobeNewsWire
20 days ago
LAFAYETTE, La., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its financial results for the three and nine months ended September 30, 2024.
Positive
Seeking Alpha
3 months ago
Upgraded Viemed Healthcare to 'Buy' due to bullish technicals, strong Q2 earnings, and promising growth trends in ventilator and sleep businesses. Bullish MACD crossover and strong buying volume signal potential for sustained share price increase. Q2 revenue hit $55 million, with notable organic growth and successful sales force restructuring driving performance.
More Viemed Healthcare Inc News

Company Profile

Viemed Healthcare, Inc. engages in the provision of home healthcare solutions. Through its subsidiaries, it supplies home medical equipment that provides post-acute respiratory services. It also offers respiratory disease management and in-home sleep testing and sleep apnea treatment. The company was founded by Casey Hoyt, Max Hoyt, and Michael Moore on December 14, 2016 and is headquartered in Lafayette, LA.

Head office Canada
CEO Casey Hoyt
Employees 996
Founded 2006
Website www.viemed.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today